A phase II trial of temsirolimus and bevacizumab

A phase II trial of temsirolimus and bevacizumab in patients with endometrial, ovarian, hepatocellular carcinoma, carcinoid, or islet cell cancer: Ovarian cancer (OC) subset¿A study of the Princess Margaret, Mayo, Southeast phase II, and California Cancer (CCCP) N01 Consortia NCI#8233.

Sponsor(s)

H. Lee Moffitt Cancer Center and Research Institute

Principal Investigator(s)John Kauh, MD
Dates10/22/2009 - 9/30/2011